Drug Search Results
More Filters [+]

Docarpamine

Alternative Names: docarpamine
Latest Update: 2024-08-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: DR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Martin Pharmaceuticals
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Docarpamine

Countries in Clinic: Australia

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Intestinal Diseases|Liver Cirrhosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DREAM

P2

Recruiting

Intestinal Diseases|Liver Cirrhosis

2023-05-31

Recent News Events

Date

Type

Title